| Literature DB >> 36181040 |
Xiaofei Lu1, Dechao Hu, Benzheng Zhou.
Abstract
To evaluate whether the higher attenuation value [Hounsfield unit (HU)] in non-contrast CT can predict pyonephrosis in patients with upper urinary tract stones (UTS). Between October 2019 and October 2021, patients with hydronephrosis or pyonephrosis secondary to upper UTS were retrospectively searched in our study. All patients with UTS were treated with percutaneous nephrostomy, percutaneous nephrolithotomy, retrograde ureteral stent or transurethral ureteroscope lithotripsy. We excluded patients treated with extracorporeal shock-wave lithotripsy. Patients whose CT was not performed in our hospital or treated in another hospital were also excluded. Clinical data regarding basic information, clinical feature, Calculi-related indicators, HU values of the renal pelvis, the thick wall of the renal pelvis on CT were collected. Univariate and multivariate logistic analyses were performed. Receiver operative characteristic curves were drawn to predict pyonephrosis. A total of 240 patients with UTS were retrospected in this research, 191 patients had hydronephrosis (Group 1), and 49 patients had hydronephrosis with pyonephrosis (Group 2). The HU value of the renal collecting system in Group 2 (mean, 15.46; range, +1/+30) was significantly higher than that in Group 1 (mean, 5.5; 5 range -6/+24) (P = .02); the receiver operative characteristic curve analysis revealed that the best cut-off value of 9.5 could predict the presence of pyonephrosis, with 71.4% sensitivity and 70.2% specificity (area under the curve = 0.613; 95% CI: 0.514-0.713). In this study, we found the HU attenuation value of the renal collecting system can be used to distinguish pyonephrosis from hydronephrosis in patients with UTS.Entities:
Mesh:
Year: 2022 PMID: 36181040 PMCID: PMC9524909 DOI: 10.1097/MD.0000000000030557
Source DB: PubMed Journal: Medicine (Baltimore) ISSN: 0025-7974 Impact factor: 1.817
Data regarding patient-related factors.
| Patient with Hy | Patient with Py | ||
|---|---|---|---|
| Patients (%) | 191 (79.6) | 49 (20.4) | |
| Age (yr) | .62 | ||
| Mean ± SD | 51.8 ± 12.16 | 56.82 ± 11.55 | |
| Range | 16–80 | 23–77 | |
| Sex (male/female) | 134/57 | 25/24 | .01 |
| Body mass index | .37 | ||
| Mean ± SD | 23.18 ± 3.78 | 22.65 ± 3.18 | |
| Range | 16.5–30.8 | 16.6–32.5 | |
| Associated comorbid condition (n/N) | |||
| DM | 41/191 | 7/49 | .26 |
| Hypertension | 74/191 | 14/49 | .18 |
| DM with HTN | 13/191 | 3/49 | .86 |
| HBV | 5/191 | 1/49 | .81 |
| HCV | 1/191 | 0 | |
| Tuberculosis | 2/191 | 0 | |
| Fever (n/N) | 15/191 | 26/49 | .001 |
| Hematuresis (n/N) | 73/191 | 13/49 | .08 |
| History of same-side urological surgery (n/N) | 52/191 | 25/49 | .001 |
| Herpes labialis | 0 | 26/49 | |
DM = diabetes mellitus, HBV = hepatitis B virus, HCV = hepatitis C virus, HTN = hypertension, Hy = hydronephrosis, Py = pyonephrosis, SD = standard deviation.
Data regarding infection-related and calculus-related factors.
| Patient with Hy | Patient with Py | ||
|---|---|---|---|
| Patients (%) | 191 (79.6) | 49 (20.4) | |
| WBC (×109/L) | 7.63 (2.73–17.32) | 12.97 (2.14–30) | <.001 |
| Neutrophils (×109/L) | 5.30 (1.37–14.03) | 11.02 (2.01–27) | <.001 |
| Serum CRP (mg/L) | 14.25 (0.28–252.12) | 102.82 (0.77–309) | <.001 |
| Serum albumin | 42.15 (12.25–53.6) | 34 (19.9–43.5) | .004 |
| Urine leukocyte (/µL) | 178.94 (0–9433) | 461.98 (0–5320) | .029 |
| WBCC | 0.26 (0–4) | 3.18 (0–43) | <.001 |
| Urine culture | <.001 | ||
| Positive | 15 (8.4%) | 18 (36.7%) | |
| Negative | 164 (91.6%) | 31 (63.3%) | |
| Location of stone (n/N) | |||
| Ureteral calculus | 161/191 | 45/49 | .18 |
| Renal calculus | 100/191 | 23/49 | .49 |
| RC with UC | 72/191 | 19/49 | .89 |
| Stone size (mm) | 10.28 (6–28) | 10.31 (6–27) | .38 |
| Stone density (HU) | 919.4 (150–1669) | 793 (198–1559) | .23 |
| Grade of hydronephrosis (n/N) | .02 | ||
| Grade ½ | 94/191 | 15/49 | |
| Grade ¾ | 97/191 | 34/49 | |
| CT value of hydronephrosis (HU) | 5.55 (-6–24) | 15.46 (1–30) | .02 |
| Staghorn calculi (n/N) | 26/191 | 6/49 | .8 |
| Thick wall of the renal pelvis (n/N) | 60/191 | 25/49 | .01 |
| Definitive surgery (n/N) | |||
| PCNL | 56/191 | 17/49 | .46 |
| URL | 145/191 | 34/49 | .62 |
| PCNL and URL | 10/191 | 2/49 | .74 |
HU = Hounsfield Unit, Hy = hydronephrosis, PCNL = percutaneous nephrolithotomy, Py = pyonephrosis, RC = renal calculus, UC = ureteral calculus, URL = ureteroscope retrograde lithotripsy, WBC = white blood cells, WBCC = white blood cells count.
Figure 1.Hounsfeld units measurement of 3 different patients in pyonephrosis and Hydronephrosis group: (A–C) different patients in Hydronephrosis group; (D–F) different patients in pyonephrosis group.
Factors in univariate and multivariate analysis for predicting pyonephrosis before operation.
| Variable | Univariate analysis | Multivariate analysis | ||
|---|---|---|---|---|
| OR (95% CI) | OR (95% CI) | |||
| Sex (male/female) | 0.206 (0.105–0.404) | <.001 | 0.522 (0.098–2.775) | .446 |
| Diabetes mellitus | 1.122 (0.793–1.587) | .262 | ||
| Hypertension | 0.938 (0.647–1.359) | .184 | ||
| Duration of symptom (d) | 1.193 (0.613–2.322) | .293 | ||
| Fever (n/N) | 10.020 (4.936–20.340) | <.001 | 2.447 (0.332–18.004) | .380 |
| Hematuresis (n/N) | 0.453 (0.213–0.964) | .078 | ||
| History of urological surgery | 6.292 (3.152–12.559) | .001 | 5.786 (1.041–32.148) | .045 |
| WBC (×109/L) | 0.116 (0.058–0.232) | <.001 | 0.074 (0.011–0.480) | .006 |
| Serum CRP (mg/L) | 0.035 (0.008–0.149) | <.001 | 0.018 (0.001–0.329) | .007 |
| Serum albumin | 0.039 (0.015–0.105) | .004 | 0.128 (0.018–0.902) | .039 |
| Urine leukocyte (/µL) | 0.213 (0.080–0.564) | .002 | 5.915 (0.535–65.407) | .147 |
| WBCC | 0.100 (0.042–0.237) | <.001 | 0.052 (0.004–0.624) | .020 |
| Urine culture | 0.132 (0.059–0.298) | <.001 | 1.063 (0.131–8.618) | .954 |
| Stone density (HU) | 0.550 (0.281–1.076) | .233 | ||
| Grade of hydronephrosis (n/N) | 0.388 (0.204–0.738) | .021 | 0.134 (0.024–0.733) | .020 |
| CT value of hydronephrosis (HU) | 0.019 (0.006–0.055) | <.001 | 0.050 (0.007–0.343) | .002 |
| Thick wall of the renal pelvis | 4.810 (2.457–9.416) | .012 | 4.867 (0.805–29.411) | .085 |
CI = confidence interval, HU = Hounsfield Unit, Hy = hydronephrosis, OR = odds ratio, WBC = white blood cells; WBCC = white blood cells count.
Figure 2.The sensitivity and specificity of independent risk factors in predicting pyonephrosis in patients with upper urinary tract stones in ROC analysis. ROC = receiver operative characteristic.